These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The beginning of clinical tolerance in solid organ allografts. Monaco AP Exp Clin Transplant; 2004 Jun; 2(1):153-61. PubMed ID: 15859922 [TBL] [Abstract][Full Text] [Related]
23. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen. Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294 [TBL] [Abstract][Full Text] [Related]
24. Status of liver and gastrointestinal transplantation at the University of Miami. Weppler D; Khan R; Fragulidis GP; Nery JR; Ricordi C; Tzakis AG Clin Transpl; 1996; ():187-201. PubMed ID: 9286568 [TBL] [Abstract][Full Text] [Related]
25. Current status of allograft tolerance in intestinal transplantation. Meier D; Rumbo M; Gondolesi GE Int Rev Immunol; 2014; 33(3):245-60. PubMed ID: 24328710 [TBL] [Abstract][Full Text] [Related]
26. Tolerance after liver transplantation: Where are we? Feng S; Bucuvalas J Liver Transpl; 2017 Dec; 23(12):1601-1614. PubMed ID: 28834221 [TBL] [Abstract][Full Text] [Related]
27. Ex vivo allotransplantation engineering: Delivery of mesenchymal stem cells prolongs rejection-free allograft survival. Soares MA; Massie JP; Rifkin WJ; Rao N; Duckworth AM; Park C; Kadle RL; David JA; Rabbani PS; Ceradini DJ Am J Transplant; 2018 Jul; 18(7):1657-1667. PubMed ID: 29359512 [TBL] [Abstract][Full Text] [Related]
28. Spontaneous resolution of acute rejection and tolerance induction with IL-2 fusion protein in vascularized composite allotransplantation. Jindal R; Unadkat J; Zhang W; Zhang D; Ng TW; Wang Y; Jiang J; Lakkis F; Rubin P; Lee WP; Gorantla VS; Zheng XX Am J Transplant; 2015 May; 15(5):1231-40. PubMed ID: 25676865 [TBL] [Abstract][Full Text] [Related]
29. Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion. Donckier V; Troisi R; Le Moine A; Toungouz M; Ricciardi S; Colle I; Van Vlierberghe H; Craciun L; Libin M; Praet M; Noens L; Stordeur P; Andrien M; Lambermont M; Gelin M; Bourgeois N; Adler M; de Hemptinne B; Goldman M Liver Transpl; 2006 Oct; 12(10):1523-8. PubMed ID: 17004249 [TBL] [Abstract][Full Text] [Related]
30. Intestinal graft versus native liver cytokine expression in a rat model of intestinal transplantation with and without donor-specific cell augmentation. Levay-Young B; Gruessner SE; Shearer JD; Cheol Kim S; Nahkleh RE; Gruessner RW J Surg Res; 2003 Sep; 114(1):78-89. PubMed ID: 13678702 [TBL] [Abstract][Full Text] [Related]
31. Rejection of intestinal allotransplants is driven by memory T helper type 17 immunity and responds to infliximab. Kroemer A; Belyayev L; Khan K; Loh K; Kang J; Duttargi A; Dhani H; Sadat M; Aguirre O; Gusev Y; Bhuvaneshwar K; Kallakury B; Cosentino C; Houlihan B; Diaz J; Moturi S; Yazigi N; Kaufman S; Subramanian S; Hawksworth J; Girlanda R; Robson SC; Matsumoto CS; Zasloff M; Fishbein TM Am J Transplant; 2021 Mar; 21(3):1238-1254. PubMed ID: 32882110 [TBL] [Abstract][Full Text] [Related]
32. Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance. Hu H; Zhu X; Joshi S; Lu L; Xia CQ; Patel JM PLoS One; 2015; 10(5):e0124705. PubMed ID: 25933390 [TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation. Birkeland SA; Hamilton-Dutoit S; Bendtzen K Transplantation; 2003 Jul; 76(1):153-8. PubMed ID: 12865802 [TBL] [Abstract][Full Text] [Related]
35. The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients. Massart A; Pallier A; Pascual J; Viklicky O; Budde K; Spasovski G; Klinger M; Sever MS; Sørensen SS; Hadaya K; Oberbauer R; Dudley C; De Fijter JW; Yussim A; Hazzan M; Wekerle T; Berglund D; De Biase C; Pérez-Sáez MJ; Mühlfeld A; Orlando G; Clemente K; Lai Q; Pisani F; Kandus A; Baas M; Bemelman F; Ponikvar JB; Mazouz H; Stratta P; Subra JF; Villemain F; Hoitsma A; Braun L; Cantarell MC; Colak H; Courtney A; Frasca GM; Howse M; Naesens M; Reischig T; Serón D; Seyahi N; Tugmen C; Alonso Hernandez A; Beňa L; Biancone L; Cuna V; Díaz-Corte C; Dufay A; Gaasbeek A; Garnier A; Gatault P; Gentil Govantes MA; Glowacki F; Gross O; Hurault de Ligny B; Huynh-Do U; Janbon B; Jiménez Del Cerro LA; Keller F; La Manna G; Lauzurica R; Le Monies De Sagazan H; Thaiss F; Legendre C; Martin S; Moal MC; Noël C; Pillebout E; Piredda GB; Puga AR; Sulowicz W; Tuglular S; Prokopova M; Chesneau M; Le Moine A; Guérif P; Soulillou JP; Abramowicz M; Giral M; Racapé J; Maggiore U; Brouard S; Abramowicz D Nephrol Dial Transplant; 2016 Jun; 31(6):1002-13. PubMed ID: 26763669 [TBL] [Abstract][Full Text] [Related]
36. Repeated Injections of IL-2 Break Renal Allograft Tolerance Induced via Mixed Hematopoietic Chimerism in Monkeys. Yamada Y; Nadazdin O; Boskovic S; Lee S; Zorn E; Smith RN; Colvin RB; Madsen JC; Cosimi AB; Kawai T; Benichou G Am J Transplant; 2015 Dec; 15(12):3055-66. PubMed ID: 26190648 [TBL] [Abstract][Full Text] [Related]
37. Achieving operational tolerance in transplantation: how can lessons from the clinic inform research directions? Chandrasekharan D; Issa F; Wood KJ Transpl Int; 2013 Jun; 26(6):576-89. PubMed ID: 23517251 [TBL] [Abstract][Full Text] [Related]
38. Challenges with Intestine and Multivisceral Re-Transplantation: Importance of Timing of Re-Transplantation and Optimal Immunosuppression. Kubal CA; Pennington C; Fridell J; Ekser B; Muhaylov P; Mangus R Ann Transplant; 2018 Feb; 23():98-104. PubMed ID: 29402878 [TBL] [Abstract][Full Text] [Related]
39. Long-term Nonhuman Primate Renal Allograft Survival Without Ongoing Immunosuppression in Recipients of Delayed Donor Bone Marrow Transplantation. Hotta K; Oura T; Dehnadi A; Boskovic S; Matsunami M; Rosales I; Smith RN; Colvin RB; Cosimi AB; Kawai T Transplantation; 2018 Apr; 102(4):e128-e136. PubMed ID: 29300231 [TBL] [Abstract][Full Text] [Related]
40. Combined Anti-CD154/CTLA4Ig Costimulation Blockade-Based Therapy Induces Donor-Specific Tolerance to Vascularized Osteomyocutaneous Allografts. Lin CH; Wang YL; Anggelia MR; Chuang WY; Cheng HY; Mao Q; Zelken JA; Lin CH; Zheng XX; Lee WP; Brandacher G Am J Transplant; 2016 Jul; 16(7):2030-41. PubMed ID: 26914847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]